The Powerful Effects of SSRI Withdrawals of Pristiq

Discontinuing Pristiq (desvenlafaxine), a serotonin-norepinephrine reuptake inhibitor (SNRI) often grouped with SSRIs due to its serotonergic activity, can produce clinically significant withdrawal symptoms known as antidepressant discontinuation syndrome. Because Pristiq has a relatively short half-life, abrupt cessation or rapid tapering can lead to pronounced neurochemical shifts in serotonin and norepinephrine levels. During withdrawal of Pristiq, patients frequently report brain zaps, dizziness, nausea, headaches, irritability, insomnia, and sensory disturbances. These symptoms can emerge within 24–72 hours of a missed dose and may vary in intensity depending on duration of use, dosage, and individual neurobiology.

Beyond physical symptoms, the psychological impact of Pristiq withdrawal can be substantial. Patients may experience rebound depression, heightened anxiety, mood instability, crying spells, and difficulty concentrating, which can be misinterpreted as relapse rather than withdrawal. In more severe cases, individuals may report depersonalization, agitation, or flu-like symptoms that interfere with daily functioning.

Gradual, medically supervised tapering from prescription drugs is essential to minimize withdrawal severity and differentiate discontinuation effects from recurrence of major depressive disorder. Clinical oversight ensures symptom monitoring, dosage adjustments, and supportive interventions to promote neurological stabilization and reduce relapse risk.

pristiq withdrawals

Table of contents

» Pristiq Treats Major Depressive Disorders in Adults

» Typical Side Effects of Taking the SSRI Pristiq

» Abruptly Discontinuing Pristiq Use is Not Recommended

» Medical Professionals Recommend a Gradual Tapering Off Process

» Key Takeaways on Withdrawal of Pristiq

» Resources


Pristiq Treats Major Depressive Disorders in Adults

Pristiq works by inhibiting the reabsorption (reuptake) of serotonin and norepinephrine in the brain, increasing the availability of these neurotransmitters in the synaptic cleft. Both neurotransmitters play critical roles in mood regulation, motivation, cognitive function, and the stress response. By enhancing serotonergic and noradrenergic signaling, Pristiq helps correct the neurochemical imbalances commonly associated with depressive episodes, including persistent sadness, low energy, impaired concentration, and loss of interest in previously rewarding activities.

Clinically, Pristiq is often prescribed as an extended-release once-daily tablet, which helps maintain steady plasma levels and improve adherence. Many adults experience gradual symptom improvement over several weeks, with reductions in emotional distress, improved sleep patterns, and better functional capacity at work or home.

In addition to alleviating core depressive symptoms, desvenlafaxine may also improve associated anxiety and somatic complaints frequently seen in MDD. As with all antidepressants, therapeutic response varies, and ongoing clinical monitoring is essential to evaluate efficacy, adjust dosing if necessary, and assess for side effects or emerging safety concerns.


Typical Side Effects of Taking the SSRI Pristiq

Like other serotonergic antidepressants, Pristiq (desvenlafaxine) can cause side effects as the body adjusts to changes in serotonin and norepinephrine activity. Most side effects are mild to moderate and tend to improve over time; however, persistent or worsening symptoms should be evaluated by a healthcare provider.

Typical Side Effects of Taking Pristiq:

  • Nausea: One of the most commonly reported effects, particularly during the first few weeks of treatment.
  • Dizziness: Often related to blood pressure changes or central nervous system adjustment.
  • Dry Mouth: Caused by reduced salivary gland stimulation.
  • Insomnia: Difficulty falling or staying asleep due to increased norepinephrine activity.
  • Fatigue or Drowsiness: Some individuals experience sedation instead of stimulation.
  • Constipation: Slowed gastrointestinal motility is a recognized effect of SNRIs.
  • Increased Sweating (Hyperhidrosis): Excess perspiration, especially at night.
  • Decreased Appetite: May lead to mild weight changes in some patients.
  • Sexual Side Effects: Reduced libido, delayed orgasm, or erectile dysfunction.
  • Elevated Blood Pressure: Dose-dependent increases in blood pressure may occur and require monitoring.

Because Pristiq directly alters serotonin and norepinephrine levels in the brain, stopping it suddenly can disrupt neurochemical stability and lead to clinically significant complications.

Reasons Why Abruptly Discontinuing Pristiq Is Not Recommended:

  • High Risk of Antidepressant Discontinuation Syndrome: Sudden cessation can trigger dizziness, nausea, headaches, and flu-like symptoms.
  • “Brain Zaps” and Sensory Disturbances: Electric-shock-like sensations, tingling, or visual disturbances are commonly reported during rapid withdrawal.
  • Rebound Depression: Depressive symptoms may return quickly and sometimes more intensely than before treatment.
  • Increased Anxiety or Irritability: Abrupt withdrawal can heighten agitation, restlessness, and mood instability.
  • Sleep Disruption: Insomnia or vivid dreams may develop within days of stopping the medication.
  • Cognitive Impairment: Difficulty concentrating, confusion, or slowed thinking can occur during withdrawal.
  • Elevated Blood Pressure Fluctuations: Sudden changes in norepinephrine regulation may affect cardiovascular stability.
  • Greater Relapse Risk: Stopping without a taper plan increases the likelihood of full depressive episode recurrence.
  • Reduced Ability to Function Daily: Physical and psychological withdrawal symptoms can interfere with work, relationships, and overall quality of life.

A gradual, medically supervised taper allows the central nervous system to recalibrate more safely and significantly reduces the severity and risks of prescription drug abuse and withdrawal.


Talk to Our Recovery Specialist
Transform Your Life Today
Talk to Our Recovery Specialist

Call Now: (239) 237-5473


What our customers are saying


Medical Professionals Recommend a Gradual Tapering Off Process

Medical professionals recommend a gradual taper when discontinuing medications like Pristiq, as the central nervous system needs time to recalibrate after prolonged neurotransmitter modulation. SNRIs alter serotonin and norepinephrine activity, and abrupt cessation can create a sudden neurochemical imbalance that triggers antidepressant discontinuation syndrome.

By systematically reducing the dosage over weeks or longer, depending on duration of use and dosage strength, clinicians allow synaptic receptors and downstream signaling pathways to adjust incrementally. This controlled reduction significantly decreases the intensity and frequency of withdrawal symptoms such as dizziness, nausea, irritability, insomnia, and sensory disturbances.

A structured taper also helps differentiate withdrawal effects from true relapse of major depressive disorder. When symptoms reemerge gradually under clinical supervision due to the potency of prescription drugs, providers can assess whether they stem from neurochemical adjustment or a return of underlying depression. This distinction is critical for determining whether further tapering, dosage stabilization, or alternative treatment is appropriate.

Gradual tapering supports patient safety and improves medication adherence during discontinuation. It also reduces the risk of functional impairment, emotional destabilization, and unnecessary reinstatement of medication at higher doses.


Talk to Our Recovery Specialist
Transform Your Life Today
Talk to Our Recovery Specialist

Call Now: (239) 237-5473

 


addiction withdrawal of pristiq

 


Key Takeaways on Withdrawal of Pristiq

  • Pristiq alters serotonin and norepinephrine levels, making it effective for major depressive disorder but also capable of causing significant withdrawal symptoms if stopped improperly.
  • Abrupt discontinuation can trigger antidepressant discontinuation syndrome, including dizziness, nausea, brain zaps, insomnia, irritability, and flu-like symptoms.
  • Psychological withdrawal effects can mimic relapse, making it difficult to distinguish between temporary neurochemical adjustment and the return of major depressive symptoms without clinical oversight.
  • Gradual tapering allows the central nervous system to stabilize, reducing the severity and duration of withdrawal symptoms while protecting overall functioning.
  • Medical supervision during discontinuation improves safety and outcomes, ensuring appropriate dose adjustments, monitoring for relapse, and minimizing unnecessary complications.

Discontinuing Pristiq can lead to a range of challenging physical and emotional symptoms, which may vary in intensity and duration for different individuals. It’s important to approach the withdrawal of Pristiq carefully to minimize discomfort. If you or someone you know is considering stopping Pristiq, consider reaching out to the WhiteSands Alcohol and Drug Rehab in Florida at 877-855-3470 to assist individuals in navigating this process safely.


Resources

If you or a loved one needs help with abuse and/or treatment, please call the WhiteSands Treatment at (877) 855-3470. Our addiction specialists can assess your recovery needs and help you get the addiction treatment that provides the best chance for your long-term recovery.

About the Author

Jaclyn

Jackie has been involved in the substance abuse and addiction treatment sector for over five years and this is something that she is truly eager about. She has a passion for writing and continuously works to create informative pieces that not only educate and inform the public about the disease of addiction but also provide solutions for those who struggle with drug and alcohol abuse.

CALL NOW FOR TREATMENT